Video

Quality improvement initiative reduces chemotherapy wastage in paediatric oncology in Pakistan

Quality improvement initiative reduces chemotherapy wastage in paediatric oncology in Pakistan

24 September 2026
Paediatric cancer treatment is a cost-effective health system investment in India

Paediatric cancer treatment is a cost-effective health system investment in India

24 September 2026
Acyclovir prophylaxis reduces varicella infections in children receiving intensive chemotherapy

Acyclovir prophylaxis reduces varicella infections in children receiving intensive chemotherapy

24 September 2026
Conservative management may be safe for retained central venous catheter fragments in children

Conservative management may be safe for retained central venous catheter fragments in children

24 September 2026
Biomarker guided PARP inhibitor maintenance improves outcomes in ovarian cancer meta analysis of phase 3 trials

Biomarker guided PARP inhibitor maintenance improves outcomes in ovarian cancer meta analysis of phase 3 trials

19 September 2026
Immune checkpoint inhibitors show setting specific benefit in ovarian cancer meta analysis of 17 randomised trials

Immune checkpoint inhibitors show setting specific benefit in ovarian cancer meta analysis of 17 randomised trials

19 September 2026
Prolgolimab plus chemotherapy improves long term survival in advanced nonsquamous NSCLC

Prolgolimab plus chemotherapy improves long term survival in advanced nonsquamous NSCLC

18 September 2026
Extended interval tarlatamab dosing shows clinical activity in previously treated small cell lung cancer

Extended interval tarlatamab dosing shows consistent clinical activity in previously treated SCLC

18 September 2026
Triplet regimen of amivantamab, lazertinib, and pemetrexed showed robust efficacy in advanced EGFR-mNSCLC

Triplet regimen of amivantamab, lazertinib, and pemetrexed showed robust efficacy in advanced EGFR-mNSCLC

18 September 2026
JS207 plus chemotherapy enables surgery and deep pathological responses in unresectable NSCLC

JS207 plus chemotherapy enables surgery and deep pathological responses in unresectable NSCLC

18 September 2026
Bladder cancer updates from the first half of 2026

Bladder cancer updates from the first half of 2026

31 July 2026
Zoldonrasib plus daraxonrasib targets KRAS G12D in metastatic pancreatic cancer with promising early results

Zoldonrasib plus daraxonrasib targets KRAS G12D in metastatic pancreatic cancer with promising early results

22 July 2026
Back to Top